Developer docs
API playgroundTry for free, no card

Search company profiles

CCS Medical

Full company profile

uuid0006xnv

Namestring
CCS Medical
Legal namestring
CCS Medical, Inc.
Websiteurl
ccsmed.com
Company typeenum
Private
Founded yearint
1994
Short descriptiontext

CCS Medical is a U.S. durable medical equipment distributor and chronic care management company that delivers continuous glucose monitors, insulin pumps, and supplies to more than 200,000 diabetes patients, augmented by the LivingConnected clinical platform and proprietary PropheSee and CeeCee AI tools for adherence and engagement.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersSt. Petersburg, United States
HQ citystring
St. Petersburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
durable medical equipment, diabetes supply distribution, chronic care management, continuous glucose monitoring, clinical care programs
Industry3 codes
PRIMARYCRAOAHAF
Durable Medical Equipment (DME) & Home Health Distribution
SECONDARYHLACAFAA
Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SIC code2 codes
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Surgical & Medical Instruments & Apparatus3841
Product category
Chronic Care Management
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Supplies Distribution
TypeHardware Sales
Description

CCS generates revenue primarily through the distribution of durable medical equipment (DME) including CGM systems, insulin pumps, and related supplies. Revenue is derived from insurance reimbursements from Medicare, Medicaid, and commercial health plans. The company is contracted with over 1800 in-network care plans.

ccsmed.com
2Clinical Services & Coaching
TypeManaged Services
Description

Revenue generated from clinical education, monitoring, and coaching programs (LivingConnected®) offered to health plans and employers as part of diabetes care management contracts.

ccsmed.com
3Data-Driven Care Partnerships
TypeSubscription Recurring
Description

Partnership revenue streams from collaborations with health plans and manufacturers focused on improving therapy adherence and patient outcomes through CCS's technology platform.

businesswire.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Pricing details2 tiers
1Standard insurance-covered supply delivery with clinical support
ModelOtherBilling cadenceMonthly
Notes

Most patients receive supplies through insurance coverage with out-of-pocket costs determined by their specific plan. No direct pricing published.

ccsmed.com
2Expedited shipping option
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Overnight shipping available for $25 additional charge

ccsmed.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 4 records shown
1LivingConnected®
Description

Evidence-based clinical program integrating device delivery with comprehensive education, monitoring, and personalized coaching for diabetes management.

ccsmed.com
+3 more records
Core offering1 text field

CCS Medical distributes continuous glucose monitors (CGM), insulin pumps, and diabetes supplies directly to patients' homes as a Durable Medical Equipment (DME) supplier, while bundling clinical education, real-time monitoring, and coaching through its LivingConnected® program. The company also offers enterprise-level AI platforms — CeeCee™ (agentic AI) and PropheSee™ (predictive analytics) — sold to health plans, employers, and providers to drive therapy adherence and reduce the cost of diabetes complications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 50% improvement in test versus control adherence outcomes through PropheSee™ deployment
+4 more records
Product overview1 text field

CCS Medical is a chronic care management organization providing a comprehensive portfolio of medical supplies and clinical programs for diabetes management. The core product portfolio includes CGM systems (Abbott FreeStyle Libre 2/3/Plus variants, Dexcom G7/15-Day) and insulin pumps (Beta Bionics iLet, Insulet Omnipod®5) for home delivery. The LivingConnected® clinical care platform integrates these devices with education, monitoring, and coaching services. AI-powered solutions include CeeCee™ (agentic AI for autonomous patient engagement) and PropheSee™ (predictive analytics for adherence intervention), which together form an enterprise-level AI system unique in the diabetes distribution industry. The LivingConnected® with Gestational Diabetes program extends specialized care to expectant mothers. With 30 years of experience, 200K+ patients on service, and partnerships with 1800+ in-network care plans, CCS delivers products, education, and AI-driven support as a unified chronic care solution.

Product and service12 records
1Abbott FreeStyle Libre 2 System
CategoryCGM System
Description

Continuous glucose monitoring system with optional glucose alarms and wear time up to 14 days, distributed to diabetes patients via CCS Medical's home-delivery DME service.

2Abbott FreeStyle Libre 2 Plus System
CategoryCGM System
Description

CGM system with automatic readings every minute and enhanced features for glucose monitoring, distributed to diabetes patients via CCS Medical.

3Abbott FreeStyle Libre 3 System
CategoryCGM System
Description

Smallest, most discreet CGM system with real-time glucose readings sent directly to a smartphone, distributed via CCS Medical's DME service.

4Abbott FreeStyle Libre 3 Plus System
CategoryCGM System
Description

CGM system with longer wear time and enhanced accuracy for continuous glucose monitoring, distributed via CCS Medical.

5Beta Bionics iLet Bionic Pancreas
CategoryInsulin Pump
Description

Fully automated insulin dosing system that acts as a bionic pancreas for diabetes management, distributed by CCS Medical.

6Dexcom G7 15 Day CGM System
CategoryCGM System
Description

Advanced CGM system approximately 60% smaller than previous Dexcom models with 15-day wear, distributed via CCS Medical.

7Dexcom G7 CGM System
CategoryCGM System
Description

Next-generation continuous glucose monitoring system with improved accuracy and user experience, distributed via CCS Medical.

8Insulet Omnipod® 5
CategoryInsulin Pump
Description

Tubeless, water-resistant insulin pump with SmartAdjust™ technology for automated insulin delivery, distributed by CCS Medical.

9LivingConnected® Clinical Care Program
CategoryClinical Care Platform
Description

Evidence-based clinical care program integrating device delivery with comprehensive diabetes education, real-time monitoring, and personalized coaching by Certified Diabetes Educators, sold to health plans, employers, and patients.

10LivingConnected® with Gestational Diabetes
CategorySpecialty Clinical Program
Description

Specialty clinical care management program for expectant mothers with gestational diabetes, providing breast pump services, lactation consulting, nutrition coaching, and remote blood glucose monitoring.

11CeeCee™ Enterprise Agentic AI Platform
CategoryAI Agentic Platform
Description

Enterprise-level agentic AI platform that autonomously interacts with patients and providers, anticipating needs, automating routine tasks and communications, and delivering personalized support at every touchpoint.

12PropheSee™ Predictive Analytics Platform
CategoryAI Predictive Analytics Platform
Description

Proprietary AI-powered predictive analytics and intervention platform that forecasts CGM therapy discontinuation with 85% accuracy within a 90-day forward window, delivering hyper-personalized interventions to drive therapy adherence, sold to health plans, employers, and providers.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-08
Description

Partnership to accelerate generative AI development using reinforcement learning. Adaptive ML helped CCS develop its CeeCee agentic AI platform using Meta Llama and AWS infrastructure. Collaboration enables autonomous patient support and operational efficiency.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-10
Description

Strategic partnership to expand access to data-driven remote care for people with diabetes. Collaboration aims to improve healthcare delivery through data access and remote monitoring, combining CCS's supply distribution and clinical programs with SweetSpot's data capabilities.

Strategic tierCoreTypeTechnology or Integration
Description

Technology partnership for ePrescribing that eliminates faxing and paper-based ordering. Parachute Health platform provides frictionless order experience with end-to-end tracking, empowering providers to focus on patient care rather than paperwork.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on developing PropheSee™ predictive analytics model. Accenture contributed data science expertise to build the platform that identifies patients at risk of non-adherence up to 90 days in advance, enabling personalized interventions.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Healthcare system partnership providing LivingConnected® diabetes education program to employees, demonstrating employer-focused GTM for diabetes care management solutions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Edgepark Medical Supplies
TypeDirect peer
Description

Edgepark is a long-standing national DME supplier serving patients with diabetes and other chronic conditions via home delivery, insurance billing, and provider referrals — directly comparable to CCS's distribution-led GTM.

2Solara Medical Supplies
TypeDirect peer
Description

Solara is a privately held DME distributor focused on diabetes CGMs, insulin pumps, and supplies, competing with CCS for the same manufacturer partnerships, payer contracts, and direct-to-patient home delivery relationships.

TypeBroad incumbent
Description

Dexcom is a leading CGM manufacturer and a current distribution partner of CCS. It is also a broad incumbent actively investing in direct-to-patient fulfillment, which positions it as both a partner and a structural threat to third-party DME distributors like CCS.

TypeDirect peer
Description

US Med is one of the largest privately held DME distributors focused exclusively on diabetes supplies, CGMs, and insulin pumps, competing head-to-head with CCS for manufacturer distribution rights, payer contracts, and patient referrals in the same US channels.

TypeDirect peer
Description

Byram Healthcare is a national DME distributor (now part of Owens & Minor) with a substantial diabetes supply business, offering direct home delivery, insurance billing, and clinical support services that overlap directly with CCS's core distribution-plus-coaching model.

TypeEmerging player
Description

Omada is a digital chronic care management platform serving employers and payers with diabetes, hypertension, and musculoskeletal programs, competing with LivingConnected® for the same enterprise buyer and overlapping with CCS on virtual coaching and outcomes-based contracts.

TypeBroad incumbent
Description

Teladoc acquired Livongo and now offers enterprise chronic condition management (including diabetes) at scale to employers and health plans — a broader incumbent competing for the same value-based chronic care contracts CCS targets with LivingConnected® and PropheSee™.

TypeBroad incumbent
Description

AdaptHealth is a publicly traded, multi-category DME provider with a large diabetes supply business alongside sleep, respiratory, and home medical equipment. It is a much broader incumbent that competes with CCS in diabetes distribution while also offering payers a one-stop DME solution.

TypeDirect peer
Description

180 Medical is a national DME distributor specializing in chronic-condition supplies with direct home delivery and insurance verification capabilities — operating a comparable distribution-plus-patient-services model in adjacent categories.

TypeOthers
Description

Welldoc powers the LivingConnected® platform and offers its own FDA-cleared digital diabetes therapeutic (BlueStar). It is a current technology partner of CCS but also a potential competitor as payers and IDNs adopt standalone digital diabetes solutions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CCS Medical

Chronic Care Managementccsmed.com

CCS Medical is a U.S. durable medical equipment distributor and chronic care management company that delivers continuous glucose monitors, insulin pumps, and supplies to more than 200,000 diabetes patients, augmented by the LivingConnected clinical platform and proprietary PropheSee and CeeCee AI tools for adherence and engagement.

CCS Medical firmographics

Firmographics
Name
CCS Medical
Legal name
CCS Medical, Inc.
Website
https://ccsmed.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
CCS Medical is a U.S. durable medical equipment distributor and chronic care management company that delivers continuous glucose monitors, insulin pumps, and supplies to more than 200,000 diabetes patients, augmented by the LivingConnected clinical platform and proprietary PropheSee and CeeCee AI tools for adherence and engagement.
Ownership category
akta.pro rank

CCS Medical industry classification

Industry
Product category
Chronic Care Management
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYCRAOAHAF
Durable Medical Equipment (DME) & Home Health Distribution
SECONDARYHLACAFAA
Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms

Keywords

  • Durable medical equipment
  • Diabetes supply distribution
  • Chronic care management
  • Continuous glucose monitoring
  • Clinical care programs

Where CCS Medical is headquartered

Location

Headquarters

HQ city
St. Petersburg
HQ country
United States
HQ region
North America

Offices9 records

Markets served

CCS Medical business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Medical Supplies Distribution: CCS generates revenue primarily through the distribution of durable medical equipment (DME) including CGM systems, insulin pumps, and related supplies. Revenue is derived from insurance reimbursements from Medicare, Medicaid, and commercial health plans. The company is contracted with over 1800 in-network care plans.
  2. Clinical Services & Coaching: Revenue generated from clinical education, monitoring, and coaching programs (LivingConnected®) offered to health plans and employers as part of diabetes care management contracts.
  3. Data-Driven Care Partnerships: Partnership revenue streams from collaborations with health plans and manufacturers focused on improving therapy adherence and patient outcomes through CCS's technology platform.

Pricing tiers

ModelBillingPrice
OtherMonthlyStandard insurance-covered supply delivery with clinical support
Unit PricingPay-as-you-goExpedited shipping option

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

CCS Medical product offering

Product offering

Core offering

CCS Medical distributes continuous glucose monitors (CGM), insulin pumps, and diabetes supplies directly to patients' homes as a Durable Medical Equipment (DME) supplier, while bundling clinical education, real-time monitoring, and coaching through its LivingConnected® program. The company also offers enterprise-level AI platforms — CeeCee™ (agentic AI) and PropheSee™ (predictive analytics) — sold to health plans, employers, and providers to drive therapy adherence and reduce the cost of diabetes complications.

Product overview

CCS Medical is a chronic care management organization providing a comprehensive portfolio of medical supplies and clinical programs for diabetes management. The core product portfolio includes CGM systems (Abbott FreeStyle Libre 2/3/Plus variants, Dexcom G7/15-Day) and insulin pumps (Beta Bionics iLet, Insulet Omnipod®5) for home delivery. The LivingConnected® clinical care platform integrates these devices with education, monitoring, and coaching services. AI-powered solutions include CeeCee™ (agentic AI for autonomous patient engagement) and PropheSee™ (predictive analytics for adherence intervention), which together form an enterprise-level AI system unique in the diabetes distribution industry. The LivingConnected® with Gestational Diabetes program extends specialized care to expectant mothers. With 30 years of experience, 200K+ patients on service, and partnerships with 1800+ in-network care plans, CCS delivers products, education, and AI-driven support as a unified chronic care solution.

Differentiator

Problem solved

Functional benefit

Brands

  • LivingConnected®: Evidence-based clinical program integrating device delivery with comprehensive education, monitoring, and personalized coaching for diabetes management.
  • CeeCee™
  • PropheSee™
  • LivingConnected® with Gestational Diabetes

Products and services

  • Abbott FreeStyle Libre 2 System Continuous glucose monitoring system with optional glucose alarms and wear time up to 14 days, distributed to diabetes patients via CCS Medical's home-delivery DME service.
  • Abbott FreeStyle Libre 2 Plus System CGM system with automatic readings every minute and enhanced features for glucose monitoring, distributed to diabetes patients via CCS Medical.
  • Abbott FreeStyle Libre 3 System Smallest, most discreet CGM system with real-time glucose readings sent directly to a smartphone, distributed via CCS Medical's DME service.
  • Abbott FreeStyle Libre 3 Plus System CGM system with longer wear time and enhanced accuracy for continuous glucose monitoring, distributed via CCS Medical.
  • Beta Bionics iLet Bionic Pancreas Fully automated insulin dosing system that acts as a bionic pancreas for diabetes management, distributed by CCS Medical.
  • Dexcom G7 15 Day CGM System Advanced CGM system approximately 60% smaller than previous Dexcom models with 15-day wear, distributed via CCS Medical.
  • Dexcom G7 CGM System Next-generation continuous glucose monitoring system with improved accuracy and user experience, distributed via CCS Medical.
  • Insulet Omnipod® 5 Tubeless, water-resistant insulin pump with SmartAdjust™ technology for automated insulin delivery, distributed by CCS Medical.
  • LivingConnected® Clinical Care Program Evidence-based clinical care program integrating device delivery with comprehensive diabetes education, real-time monitoring, and personalized coaching by Certified Diabetes Educators, sold to health plans, employers, and patients.
  • LivingConnected® with Gestational Diabetes Specialty clinical care management program for expectant mothers with gestational diabetes, providing breast pump services, lactation consulting, nutrition coaching, and remote blood glucose monitoring.
  • CeeCee™ Enterprise Agentic AI Platform Enterprise-level agentic AI platform that autonomously interacts with patients and providers, anticipating needs, automating routine tasks and communications, and delivering personalized support at every touchpoint.
  • PropheSee™ Predictive Analytics Platform Proprietary AI-powered predictive analytics and intervention platform that forecasts CGM therapy discontinuation with 85% accuracy within a 90-day forward window, delivering hyper-personalized interventions to drive therapy adherence, sold to health plans, employers, and providers.

Quantifiable outcome

  • 50% improvement in test versus control adherence outcomes through PropheSee™ deployment
  • +4 more outcomes

Companies that use CCS Medical

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles5 records

CCS Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature4 records

CCS Medical partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Adaptive MLcoreStrategic or Co-development Partner · 8 May 2026Partnership to accelerate generative AI development using reinforcement learning. Adaptive ML helped CCS develop its CeeCee agentic AI platform using Meta Llama and AWS infrastructure. Collaboration enables autonomous patient support and operational efficiency.
  • SweetSpotcoreStrategic or Co-development Partner · 10 February 2026Strategic partnership to expand access to data-driven remote care for people with diabetes. Collaboration aims to improve healthcare delivery through data access and remote monitoring, combining CCS's supply distribution and clinical programs with SweetSpot's data capabilities.
  • Parachute HealthcoreTechnology or IntegrationTechnology partnership for ePrescribing that eliminates faxing and paper-based ordering. Parachute Health platform provides frictionless order experience with end-to-end tracking, empowering providers to focus on patient care rather than paperwork.
  • AccenturecoreStrategic or Co-development PartnerCollaboration on developing PropheSee™ predictive analytics model. Accenture contributed data science expertise to build the platform that identifies patients at risk of non-adherence up to 90 days in advance, enabling personalized interventions.
  • United Regional Health Care SystemminorGTM or Marketing PartnerHealthcare system partnership providing LivingConnected® diabetes education program to employees, demonstrating employer-focused GTM for diabetes care management solutions.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

CCS Medical competitors and assessment

Company assessment

Direct peers

  • Edgepark Medical Supplies: Edgepark is a long-standing national DME supplier serving patients with diabetes and other chronic conditions via home delivery, insurance billing, and provider referrals — directly comparable to CCS's distribution-led GTM.
  • Solara Medical Supplies: Solara is a privately held DME distributor focused on diabetes CGMs, insulin pumps, and supplies, competing with CCS for the same manufacturer partnerships, payer contracts, and direct-to-patient home delivery relationships.
  • US Med: US Med is one of the largest privately held DME distributors focused exclusively on diabetes supplies, CGMs, and insulin pumps, competing head-to-head with CCS for manufacturer distribution rights, payer contracts, and patient referrals in the same US channels.
  • Byram Healthcare: Byram Healthcare is a national DME distributor (now part of Owens & Minor) with a substantial diabetes supply business, offering direct home delivery, insurance billing, and clinical support services that overlap directly with CCS's core distribution-plus-coaching model.
  • 180 Medical: 180 Medical is a national DME distributor specializing in chronic-condition supplies with direct home delivery and insurance verification capabilities — operating a comparable distribution-plus-patient-services model in adjacent categories.

Broad incumbents

  • Dexcom: Dexcom is a leading CGM manufacturer and a current distribution partner of CCS. It is also a broad incumbent actively investing in direct-to-patient fulfillment, which positions it as both a partner and a structural threat to third-party DME distributors like CCS.
  • Teladoc Health (Livongo): Teladoc acquired Livongo and now offers enterprise chronic condition management (including diabetes) at scale to employers and health plans — a broader incumbent competing for the same value-based chronic care contracts CCS targets with LivingConnected® and PropheSee™.
  • AdaptHealth: AdaptHealth is a publicly traded, multi-category DME provider with a large diabetes supply business alongside sleep, respiratory, and home medical equipment. It is a much broader incumbent that competes with CCS in diabetes distribution while also offering payers a one-stop DME solution.

Emerging players

  • Omada Health: Omada is a digital chronic care management platform serving employers and payers with diabetes, hypertension, and musculoskeletal programs, competing with LivingConnected® for the same enterprise buyer and overlapping with CCS on virtual coaching and outcomes-based contracts.

Others

  • Welldoc: Welldoc powers the LivingConnected® platform and offers its own FDA-cleared digital diabetes therapeutic (BlueStar). It is a current technology partner of CCS but also a potential competitor as payers and IDNs adopt standalone digital diabetes solutions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

CCS Medical social profiles

Digital presence

CCS Medical compliance and trust

Trust signal

Compliance8 records

CCS Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CCS Medical leadership team

Management profile

Number of profiles

Profiles6 records

CCS Medical funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CCS Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CCS Medical

What does CCS Medical do?

CCS Medical distributes continuous glucose monitors (CGM), insulin pumps, and diabetes supplies directly to patients' homes as a Durable Medical Equipment (DME) supplier, while bundling clinical education, real-time monitoring, and coaching through its LivingConnected® program. The company also offers enterprise-level AI platforms — CeeCee™ (agentic AI) and PropheSee™ (predictive analytics) — sold to health plans, employers, and providers to drive therapy adherence and reduce the cost of diabetes complications.

Is CCS Medical a public or private company?

CCS Medical is a private company. It is classified as unknown and is currently operating.

When was CCS Medical founded?

CCS Medical was founded in 1994. It employs 1,001 to 5,000 people.

Where is CCS Medical based?

CCS Medical is headquartered in St. Petersburg, United States, in the North America region.

How does CCS Medical make money?

Three revenue lines are on record. Medical Supplies Distribution is the primary driver. The others are clinical Services & Coaching and data-Driven Care Partnerships.

Who are CCS Medical's main competitors?

Direct peers on record are Edgepark Medical Supplies, Solara Medical Supplies, US Med, Byram Healthcare and 180 Medical. Broad incumbents are Dexcom, Teladoc Health (Livongo) and AdaptHealth. Omada Health is listed as an emerging player. Welldoc is listed as an others.

Does CCS Medical have an API?

No public API is recorded for CCS Medical.

What industry is CCS Medical in?

CCS Medical's product category is Chronic Care Management. Its primary akta.pro industry code is CRAOAHAF, Durable Medical Equipment (DME) & Home Health Distribution, with a secondary code of HLACAFAA, Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF). Its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogNew Data Show CCS’s Predictive Analytics and Intervention Platform Is Highly Effective in Driving Continuous Glucose Monitoring Adherence in Medicare PopulationCCS announced that its AI-powered PropheSee platform identified about 28% of 55,000 Medicare fee-for-service patients at risk of stopping continuous glucose monitoring, saving over $10 million in taxpayer dollars. The platform, launched in June 2024, achieved 85% accuracy in predicting nonadherence within 30 days and was awarded Best Predictive Analytics Solution in May 2025.Business Wire BlogCrisis Looms in Diabetes Care: New Study from CCS Reveals Critical Gaps in Patient Education as Provider Burnout IntensifiesCCS surveyed over 100 U.S. primary care physicians and endocrinologists, finding 85% of endocrinologists and 58% of PCPs overwhelmed by rising diabetes patients. The report shows less than half of patients receive formal education and coaching, and health plans pressure clinicians to prescribe through pharmacies rather than DME providers.Business Wire BlogPeople Living with Diabetes Fare Better and Have Lower Total Costs of Care When a Continuous Glucose Monitor Is Provided Through Medical Benefit Instead of Pharmacy BenefitCCS announced peer-reviewed research showing diabetes patients using CGMs through a medical benefit have 35% lower annual costs and 23% higher adherence than those using a pharmacy benefit. The study, published in JMIR Diabetes, also found higher therapy reinitiation rates for medical-benefit users.Business Wire BlogCCS Launches PropheSee™, an AI-Powered Predictive Model that Improves Therapy Adherence for People Living with DiabetesCCS launched PropheSee, an AI-powered predictive model to improve adherence to continuous glucose monitoring devices for diabetes patients. The model identifies high-risk patients and drives personalized interventions, increasing adherence by up to 50% and saving up to $2,200 per patient annually.PR NewswireCCS Announces Innovative Partnership with Welldoc and ZeOmega Aimed at Helping People with Chronic Conditions Lead Healthier Lives while Reducing Healthcare CostsCCS announced a partnership with Welldoc and ZeOmega to integrate clinical device and care utilization data into its LivingConnected chronic care program. The collaboration aims to improve patient outcomes and reduce costs, with LivingConnected already delivering 45% cost savings for one employer group.PR NewswireCCS Announces Company Expansion Focused on Accelerating Innovation in Home-Based Diabetes Care ManagementCCS announced an expansion of its home-based diabetes care services, adding education, monitoring, and coaching. The company supports over 200,000 patients and delivered 1.2 million shipments annually. Its LivingConnected program yielded a 45% cost reduction for enrolled employees.PR NewswireCCS Medical Names Tony Vahedian as Chief Executive OfficerCCS Medical, Inc. has appointed Tony Vahedian as its new Chief Executive Officer, effective October 26, 2020. Vahedian joins from Cardinal Health, where he served as President of Cardinal Health Canada, bringing over 25 years of healthcare industry experience to lead the company's growth in home medical supplies and digital health services.GlobeNewswireDarioHealth Announces Strategic Partnership with CCS MedicalDarioHealth announced a strategic partnership with CCS Medical, providing live data access to CCS Medical's LivingConnected diabetes program via its API. CCS Medical will join DarioHealth's Insurance Provider Network, and DarioHealth expects further alliances over coming months.PR NewswireCCS Connects -- the Longest Running Digital Diabetes Self-Management Program -- Earns DEAP Accreditation from AADECCS Connects, a diabetes self-management program from CCS Medical, earned DEAP accreditation from AADE on December 30, 2016. The program, created in 1999, reports 95% member satisfaction and 25% higher adherence to recommended exams. It aims to reduce diabetes-related ER visits and hospitalizations.PR NewswireCCS Connects -- the Longest Running Digital Diabetes Self-Management Program -- Earns DEAP Accreditation from AADECCS Connects, a diabetes education program from CCS Medical, received DEAP accreditation from the American Association of Diabetes Educators on December 30, 2016, becoming the longest-running digital diabetes self-management program of its kind since its creation in 1999. The program reports a 95% long-term member satisfaction rate and 25% higher adherence to recommended exams compared to national standards for HEDIS and STAR-related outcomes. CCS Connects operates virtually through phone, email, webinar, and Skype, connecting patients with Certified Diabetes Educators for ongoing individualized sessions focused on nutrition, behavioral changes, and goal setting.